Showing 2804 results
-
Press release /Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in…
-
Event /Novartis announces the company’s financial results for the second quarter and first half of 2025.
-
Event /Novartis will announce the company’s financial results for the third quarter of 2025.
-
-
-
-
Biography /
-
-
Press release /Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global…
-
Media Library /